The chemical class of Fibrillin-3 activators primarily consists of compounds that influence the TGF-β signaling pathway, which is closely related to the function and regulation of microfibrils in connective tissue. These activators work by various mechanisms, including the inhibition of TGF-β receptors, modulation of TGF-β release, and interference with TGF-β receptor kinases. For example, Losartan, Tranilast, and Pirfenidone indirectly affect fibrillin-3 by modulating TGF-β signaling, a pathway crucial for the regulation of microfibrils and extracellular matrix composition. Inhibitors of TGF-β receptor type I, such as SB-431542, A8301, LY364947, GW788388, RepSox, and Galunisertib, demonstrate the ability for modulation of TGF-β signaling, indirectly influencing the activity of fibrillin-3.
Additionally, compounds like Spironolactone, which have been shown to modulate TGF-β signaling, and Vitamin A, known for its role in extracellular matrix production, highlight the diverse mechanisms through which connective tissue dynamics can be influenced, impacting fibrillin-3. This class of chemicals is characterized by their ability to interact with key components of the TGF-β signaling pathway or to influence the synthesis and remodeling of the extracellular matrix. By modulating these processes, they provide indirect ways to influence the function and regulation of fibrillin-3, which is integral to the structural and functional integrity of connective tissues. This chemical class offers insight into the complex interplay between growth factor signaling, extracellular matrix composition, and structural protein function, all of which are integral to the biological role of fibrillin-3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $30.00 $101.00 $277.00 $959.00 | 2 | |
Tranilast is known to inhibit TGF-β release and could indirectly affect fibrillin-3 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB-431542 is an inhibitor of TGF-β receptor type I, potentially affecting fibrillin-3 indirectly. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
A8301 is another TGF-β receptor type I inhibitor, potentially influencing fibrillin-3 activity. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $105.00 $153.00 | 4 | |
LY364947, a TGF-β receptor kinase inhibitor, could indirectly modulate fibrillin-3. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
GW788388 is a potent inhibitor of TGF-β receptors, potentially affecting fibrillin-3. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
RepSox inhibits TGF-β receptor I, possibly influencing fibrillin-3 indirectly. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $209.00 $352.00 | 3 | |
LY2157299 inhibits TGF-β receptor I kinase, potentially impacting fibrillin-3. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
Spironolactone has been shown to modulate TGF-β signaling, possibly influencing fibrillin-3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid influences extracellular matrix production and could indirectly affect fibrillin-3. | ||||||